Leramistat
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Leramistat, covering 2024-08-09 to 2025-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Leramistat in Patients With IPF [Phase 2]